Metabolic Diseases
|
LR19052
|
Diabetes
|
Research
complete
|
Preclinical
complete
|
Phase I
complete
|
Phase II
complete
|
Phase III
Proceeding
|
|
Zemiglo® combination drug (Korea)
|
Research
complete
Research
complete
|
Preclinical
complete
Preclinical
complete
|
Phase I
complete
Phase I
complete
|
Phase II
complete
Phase II
complete
|
Phase III
Proceeding
Phase III
Proceeding
|
NDA
Proceeding
Phase III
Proceeding
|
LR19051
|
Diabetes
|
Research
complete
|
Preclinical
complete
|
Phase I
Proceeding
|
Phase II
Before proceeding
|
Phase III
Before proceeding
|
|
Zemiglo® combination drug (Thailand)
|
Research
complete
Research
complete
|
Preclinical
complete
Preclinical
complete
|
Phase I
Proceeding
Phase I
Proceeding
|
Phase II
Before proceeding
Phase II
Before proceeding
|
Phase III
Before proceeding
Phase III
Before proceeding
|
NDA
Proceeding
Phase III
Proceeding
|
LR19123
|
Diabetes
|
Research
complete
|
Preclinical
Proceeding
|
Phase I
Before proceeding
|
Phase II
Before proceeding
|
Phase III
Before proceeding
|
|
|
Research
complete
Research
complete
|
Preclinical
Proceeding
Preclinical
Proceeding
|
Phase I
Before proceeding
Phase I
Before proceeding
|
Phase II
Before proceeding
Phase II
Before proceeding
|
Phase III
Before proceeding
Phase III
Before proceeding
|
NDA
Proceeding
Phase III
Proceeding
|
LR19074
|
Gout
|
Research
complete
|
Preclinical
complete
|
Phase I
Proceeding
|
Phase II
Before proceeding
|
Phase III
Before proceeding
|
|
US
|
Research
complete
Research
complete
|
Preclinical
Proceeding
Preclinical
Proceeding
|
Phase I
Proceeding
Phase I
Proceeding
|
Phase II
Before proceeding
Phase II
Before proceeding
|
Phase III
Before proceeding
Phase III
Before proceeding
|
NDA
Proceeding
Phase III
Proceeding
|
LR19021
|
Obesity
|
Research
complete
|
Preclinical
Proceeding
|
Phase I
Before proceeding
|
Phase II
Before proceeding
|
Phase III
Before proceeding
|
|
US
|
Research
complete
Research
complete
|
Preclinical
Proceeding
Preclinical
Proceeding
|
Phase I
Before proceeding
Phase I
Before proceeding
|
Phase II
Before proceeding
Phase II
Before proceeding
|
Phase III
Before proceeding
Phase III
Before proceeding
|
NDA
Proceeding
Phase III
Proceeding
|
LR19020
|
Obesity
|
Research
Proceeding
|
Preclinical
Before proceeding
|
Phase I
Before proceeding
|
Phase II
Before proceeding
|
Phase III
Before proceeding
|
|
|
Research
Proceeding
Research
Proceeding
|
Preclinical
Before proceeding
Preclinical
Before proceeding
|
Phase I
Before proceeding
Phase I
Before proceeding
|
Phase II
Before proceeding
Phase II
Before proceeding
|
Phase III
Before proceeding
Phase III
Before proceeding
|
NDA
Proceeding
Phase III
Proceeding
|
LR19156
|
Obesity
|
Research
Proceeding
|
Preclinical
Before proceeding
|
Phase I
Before proceeding
|
Phase II
Before proceeding
|
Phase III
Before proceeding
|
|
|
Research
Proceeding
Research
Proceeding
|
Preclinical
Before proceeding
Preclinical
Before proceeding
|
Phase I
Before proceeding
Phase I
Before proceeding
|
Phase II
Before proceeding
Phase II
Before proceeding
|
Phase III
Before proceeding
Phase III
Before proceeding
|
NDA
Proceeding
Phase III
Proceeding
|
LR20056
|
NASH (nonalcoholic steatohepatitis)
|
Research
Proceeding
|
Preclinical
Before proceeding
|
Phase I
Before proceeding
|
Phase II
Before proceeding
|
Phase III
Before proceeding
|
|
In Partnership with
|
Research
Proceeding
Research
Proceeding
|
Preclinical
Before proceeding
Preclinical
Before proceeding
|
Phase I
Before proceeding
Phase I
Before proceeding
|
Phase II
Before proceeding
Phase II
Before proceeding
|
Phase III
Before proceeding
Phase III
Before proceeding
|
NDA
Proceeding
Phase III
Proceeding
|
LR19018
|
NASH (nonalcoholic steatohepatitis)
|
Research
Proceeding
|
Preclinical
Before proceeding
|
Phase I
Before proceeding
|
Phase II
Before proceeding
|
Phase III
Before proceeding
|
|
|
Research
Proceeding
Research
Proceeding
|
Preclinical
Before proceeding
Preclinical
Before proceeding
|
Phase I
Before proceeding
Phase I
Before proceeding
|
Phase II
Before proceeding
Phase II
Before proceeding
|
Phase III
Before proceeding
Phase III
Before proceeding
|
NDA
Proceeding
Phase III
Proceeding
|
LR20010
|
NASH (nonalcoholic steatohepatitis)
|
Research
Proceeding
|
Preclinical
Before proceeding
|
Phase I
Before proceeding
|
Phase II
Before proceeding
|
Phase III
Before proceeding
|
|
|
Research
Proceeding
Research
Proceeding
|
Preclinical
Before proceeding
Preclinical
Before proceeding
|
Phase I
Before proceeding
Phase I
Before proceeding
|
Phase II
Before proceeding
Phase II
Before proceeding
|
Phase III
Before proceeding
Phase III
Before proceeding
|
NDA
Proceeding
Phase III
Proceeding
|
LR19131
|
NASH (nonalcoholic steatohepatitis)
|
Research
Proceeding
|
Preclinical
Before proceeding
|
Phase I
Before proceeding
|
Phase II
Before proceeding
|
Phase III
Before proceeding
|
|
|
Research
Proceeding
Research
Proceeding
|
Preclinical
Before proceeding
Preclinical
Before proceeding
|
Phase I
Before proceeding
Phase I
Before proceeding
|
Phase II
Before proceeding
Phase II
Before proceeding
|
Phase III
Before proceeding
Phase III
Before proceeding
|
NDA
Proceeding
NDA
Proceeding
|
Oncology
|
LR19127
|
Oncology
|
Research
complete
|
Preclinical
complete
|
Phase I
Before proceeding
|
Phase II
Before proceeding
|
Phase III
Before proceeding
|
|
In Partnership with (US)
|
Research
complete
Research
complete
|
Preclinical
complete
Preclinical
complete
|
Phase I
Before proceeding
Phase I
Before proceeding
|
Phase II
Before proceeding
Phase II
Before proceeding
|
Phase III
Before proceeding
Phase III
Before proceeding
|
NDA
Proceeding
Phase III
Proceeding
|
LR19125
|
Oncology
|
Research
complete
|
Preclinical
complete
|
Phase I
Before proceeding
|
Phase II
Before proceeding
|
Phase III
Before proceeding
|
|
In Partnership with (Europe )
|
Research
complete
Research
complete
|
Preclinical
complete
Preclinical
complete
|
Phase I
Before proceeding
Phase I
Before proceeding
|
Phase II
Before proceeding
Phase II
Before proceeding
|
Phase III
Before proceeding
Phase III
Before proceeding
|
NDA
Proceeding
Phase III
Proceeding
|
LR20011
|
Oncology
|
Research
Proceeding
|
Preclinical
Before proceeding
|
Phase I
Before proceeding
|
Phase II
Before proceeding
|
Phase III
Before proceeding
|
|
In Partnership with (US)
|
Research
Proceeding
Research
Proceeding
|
Preclinical
Before proceeding
Preclinical
Before proceeding
|
Phase I
Before proceeding
Phase I
Before proceeding
|
Phase II
Before proceeding
Phase II
Before proceeding
|
Phase III
Before proceeding
Phase III
Before proceeding
|
NDA
Proceeding
Phase III
Proceeding
|
LR20009
|
Oncology
|
Research
Proceeding
|
Preclinical
Before proceeding
|
Phase I
Before proceeding
|
Phase II
Before proceeding
|
Phase III
Before proceeding
|
|
|
Research
Proceeding
Research
Proceeding
|
Preclinical
Before proceeding
Preclinical
Before proceeding
|
Phase I
Before proceeding
Phase I
Before proceeding
|
Phase II
Before proceeding
Phase II
Before proceeding
|
Phase III
Before proceeding
Phase III
Before proceeding
|
NDA
Proceeding
Phase III
Proceeding
|
LR19129
|
Oncology
|
Research
Proceeding
|
Preclinical
Before proceeding
|
Phase I
Before proceeding
|
Phase II
Before proceeding
|
Phase III
Before proceeding
|
|
In Partnership with
|
Research
Proceeding
Research
Proceeding
|
Preclinical
Before proceeding
Preclinical
Before proceeding
|
Phase I
Before proceeding
Phase I
Before proceeding
|
Phase II
Before proceeding
Phase II
Before proceeding
|
Phase III
Before proceeding
Phase III
Before proceeding
|
NDA
Proceeding
Phase III
Proceeding
|
LR19023
|
Oncology
|
Research
Proceeding
|
Preclinical
Before proceeding
|
Phase I
Before proceeding
|
Phase II
Before proceeding
|
Phase III
Before proceeding
|
|
|
Research
Proceeding
Research
Proceeding
|
Preclinical
Before proceeding
Preclinical
Before proceeding
|
Phase I
Before proceeding
Phase I
Before proceeding
|
Phase II
Before proceeding
Phase II
Before proceeding
|
Phase III
Before proceeding
Phase III
Before proceeding
|
NDA
Proceeding
Phase III
Proceeding
|
LR19155
|
Oncology
|
Research
Proceeding
|
Preclinical
Before proceeding
|
Phase I
Before proceeding
|
Phase II
Before proceeding
|
Phase III
Before proceeding
|
|
|
Research
Proceeding
Research
Proceeding
|
Preclinical
Before proceeding
Preclinical
Before proceeding
|
Phase I
Before proceeding
Phase I
Before proceeding
|
Phase II
Before proceeding
Phase II
Before proceeding
|
Phase III
Before proceeding
Phase III
Before proceeding
|
NDA
Proceeding
Phase III
Proceeding
|
LR20018
|
Oncology
|
Research
Proceeding
|
Preclinical
Before proceeding
|
Phase I
Before proceeding
|
Phase II
Before proceeding
|
Phase III
Before proceeding
|
|
|
Research
Proceeding
Research
Proceeding
|
Preclinical
Before proceeding
Preclinical
Before proceeding
|
Phase I
Before proceeding
Phase I
Before proceeding
|
Phase II
Before proceeding
Phase II
Before proceeding
|
Phase III
Before proceeding
Phase III
Before proceeding
|
NDA
Proceeding
Phase III
Proceeding
|
Immunology
|
LR19055
|
Autoimmune Disease
|
Research
complete
|
Preclinical
complete
|
Phase I
complete
|
Phase II
complete
|
Phase III
Proceeding
|
|
Humira® biosimilar
|
Research
complete
Research
complete
|
Preclinical
complete
Preclinical
complete
|
Phase I
complete
Phase I
complete
|
Phase II
complete
Phase II
complete
|
Phase III
Proceeding
Phase III
Proceeding
|
NDA
Proceeding
Phase III
Proceeding
|
LR19025
|
Degenerative Disease
|
Research
Proceeding
|
Preclinical
Before proceeding
|
Phase I
Before proceeding
|
Phase II
Before proceeding
|
Phase III
Before proceeding
|
|
In Partnership with
|
Research
Proceeding
Research
Proceeding
|
Preclinical
Before proceeding
Preclinical
Before proceeding
|
Phase I
Before proceeding
Phase I
Before proceeding
|
Phase II
Before proceeding
Phase II
Before proceeding
|
Phase III
Before proceeding
Phase III
Before proceeding
|
NDA
Before proceeding
Phase III
Before proceeding
|
LR19024
|
Degenerative Disease
|
Research
Proceeding
|
Preclinical
Before proceeding
|
Phase I
Before proceeding
|
Phase II
Before proceeding
|
Phase III
Before proceeding
|
|
|
Research
Proceeding
Research
Proceeding
|
Preclinical
Before proceeding
Preclinical
Before proceeding
|
Phase I
Before proceeding
Phase I
Before proceeding
|
Phase II
Before proceeding
Phase II
Before proceeding
|
Phase III
Before proceeding
Phase III
Before proceeding
|
NDA
Before proceeding
Phase III
Before proceeding
|